Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1527249
Disease: Colorectal Cancer
Colorectal Cancer
0.090 Biomarker disease BEFREE The purpose of this study is to evaluate the correlation between KRAS mutation, <sup>18</sup>F-FDG uptake, and metastatic pattern in advanced stage colorectal cancer (CRC) patients. 28161825 2017
CUI: C1527249
Disease: Colorectal Cancer
Colorectal Cancer
0.090 Biomarker disease BEFREE In vivo biodistribution studies and [(18)F]FDG-PET imaging were performed on mice bearing human colorectal cancer (HCT116 and SW480) xenografts after injection of bevacizumab with 5-FU, leucovorin, and irinotecan (FOLFIRI). 27177629 2017
CUI: C1527249
Disease: Colorectal Cancer
Colorectal Cancer
0.090 GeneticVariation disease BEFREE Genetic Alterations in Colorectal Cancer Have Different Patterns on 18F-FDG PET/CT. 26018692 2016
CUI: C1527249
Disease: Colorectal Cancer
Colorectal Cancer
0.090 AlteredExpression disease BEFREE The analytical results confirmed that correlation between 18F-FDG uptake and Ki-67 expression was extremely significant in TETs, significant in gastrointestinal stromal tumors (GISTs), moderate in patients with lung, breast, bone and soft tissue, pancreatic, oral, thoracic, and uterine and ovarian cancers, average in brain, esophageal and colorectal cancers, and poor in head and neck, thyroid, gastric and malignant melanoma tumors. 26038827 2016
CUI: C1527249
Disease: Colorectal Cancer
Colorectal Cancer
0.090 Biomarker disease BEFREE Regulation of 18F-FDG accumulation in colorectal cancer cells with mutated KRAS. 25453050 2015
CUI: C1527249
Disease: Colorectal Cancer
Colorectal Cancer
0.090 Biomarker disease BEFREE (18)F-FDG PET/CT scans may be useful for predicting the KRAS status of metastatic CRC and help in determining the therapeutic strategies against metastatic CRC. 26135109 2015
CUI: C1527249
Disease: Colorectal Cancer
Colorectal Cancer
0.090 Biomarker disease BEFREE The objective of this study was to correlate the association between mutated KRAS and wild-type colorectal cancer (CRC) by using various F-FDG PET-related parameters. 24978328 2015
CUI: C1527249
Disease: Colorectal Cancer
Colorectal Cancer
0.090 Biomarker disease BEFREE In vivo, tumor growth inhibition, (18)F-fluoro-deoxy-glucose positron emission tomography (FDG-PET), and proton nuclear magnetic resonance were carried out to evaluate the growth inhibitory and metabolic responses, respectively, in CRC xenografts. 22173548 2012
CUI: C1527249
Disease: Colorectal Cancer
Colorectal Cancer
0.090 GeneticVariation disease BEFREE Evaluation of NTHL1, NEIL1, NEIL2, MPG, TDG, UNG and SMUG1 genes in familial colorectal cancer predisposition. 17029639 2006